Difference between revisions of "PEDS5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
[checked revision] | [checked revision] |
(9 intermediate revisions by the same user not shown) | |||
Line 16: | Line 16: | ||
!'''Date of Last Editor Review''' | !'''Date of Last Editor Review''' | ||
!'''Notes''' | !'''Notes''' | ||
+ | |- | ||
+ | |CHAPTER 2 (HAEMATOLYMPHOID DISORDERS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[PEDS5:Chronic_myeloid_leukaemia_(CML)|Chronic myeloid leukaemia (CML)]] | |[[PEDS5:Chronic_myeloid_leukaemia_(CML)|Chronic myeloid leukaemia (CML)]] | ||
Line 434: | Line 454: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 3 (CNS TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[PEDS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]] | |[[PEDS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]] | ||
Line 940: | Line 980: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 4 (PERIPHERAL NEUROBLASTIC TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[PEDS5:Ganglioneuroma|Ganglioneuroma]] | |[[PEDS5:Ganglioneuroma|Ganglioneuroma]] | ||
Line 985: | Line 1,045: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 5 (EYE TUMOURS) |
− | + | | | |
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | |[[PEDS5: | + | |[[PEDS5:Epibulbar_choristoma|Epibulbar choristoma]] |
|Disease | |Disease | ||
| | | | ||
Line 1,007: | Line 1,076: | ||
| | | | ||
|- | |- | ||
− | |[[PEDS5: | + | |[[PEDS5:Epibulbar_osseous_choristoma|Epibulbar osseous choristoma]] |
|Disease | |Disease | ||
| | | | ||
Line 1,018: | Line 1,087: | ||
| | | | ||
|- | |- | ||
− | |[[PEDS5:Conjunctival_junctional,_compound,_and_subepithelial_naevi|Conjunctival junctional, compound, and subepithelial naevi]] | + | |[[PEDS5:Phakomatous_choristoma|Phakomatous choristoma]] |
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[PEDS5:Conjunctival_junctional,_compound,_and_subepithelial_naevi|Conjunctival junctional, compound, and subepithelial naevi]] | ||
|Disease | |Disease | ||
| | | | ||
Line 1,105: | Line 1,185: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 6 (SOFT TISSUE AND BONE TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[PEDS5:Lipomatosis|Lipomatosis]] | |[[PEDS5:Lipomatosis|Lipomatosis]] | ||
Line 2,172: | Line 2,272: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 7 (GERM CELL TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[PEDS5:Intratubular_germ_cell_neoplasia_(male_gonadal)|Intratubular germ cell neoplasia (male gonadal)]] | |[[PEDS5:Intratubular_germ_cell_neoplasia_(male_gonadal)|Intratubular germ cell neoplasia (male gonadal)]] | ||
Line 2,327: | Line 2,447: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 8 (RENAL AND MALE GENITAL TUMOURS) |
− | + | | | |
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | |[[PEDS5: | + | |[[PEDS5:Paediatric_cystic_nephroma|Paediatric cystic nephroma]] |
|Disease | |Disease | ||
| | | | ||
Line 2,349: | Line 2,478: | ||
| | | | ||
|- | |- | ||
− | |[[PEDS5:Renal_cell_carcinoma_with_MiT_translocations|Renal cell carcinoma with MiT translocations]] | + | |[[PEDS5:Nephroblastoma|Nephroblastoma]] |
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[PEDS5:Renal_cell_carcinoma_with_MiT_translocations|Renal cell carcinoma with MiT translocations]] | ||
|Disease | |Disease | ||
| | | | ||
Line 2,502: | Line 2,642: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 9 (FEMALE GENITAL TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[PEDS5:Ovarian_fibroma|Ovarian fibroma]] | |[[PEDS5:Ovarian_fibroma|Ovarian fibroma]] | ||
Line 2,635: | Line 2,795: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 10 (BREAST TUMOURS) |
− | + | | | |
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | |[[PEDS5: | + | |[[PEDS5:Fibroepithelial_tumours_|Fibroepithelial tumours]] |
|Disease | |Disease | ||
| | | | ||
Line 2,657: | Line 2,826: | ||
| | | | ||
|- | |- | ||
− | |[[PEDS5: | + | |[[PEDS5:Juvenile_fibroadenoma|Juvenile fibroadenoma]] |
|Disease | |Disease | ||
| | | | ||
Line 2,668: | Line 2,837: | ||
| | | | ||
|- | |- | ||
− | |[[PEDS5: | + | |[[PEDS5:Juvenile_papillomatosis|Juvenile papillomatosis]] |
|Disease | |Disease | ||
| | | | ||
Line 2,679: | Line 2,848: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 11 (DIGESTIVE SYSTEM TUMOUR) |
− | + | | | |
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | |[[PEDS5: | + | |[[PEDS5:Hepatoblastoma|Hepatoblastoma]] |
|Disease | |Disease | ||
| | | | ||
Line 2,701: | Line 2,879: | ||
| | | | ||
|- | |- | ||
− | |[[PEDS5: | + | |[[PEDS5:Fibrolamellar_variant_of_hepatocellular_carcinoma|Fibrolamellar variant of hepatocellular carcinoma]] |
|Disease | |Disease | ||
| | | | ||
Line 2,712: | Line 2,890: | ||
| | | | ||
|- | |- | ||
− | |[[PEDS5:Calcifying_nested_stromal-epithelial_tumour|Calcifying nested stromal-epithelial tumour]] | + | |[[PEDS5:Paediatric_hepatocellular_carcinoma|Paediatric hepatocellular carcinoma]] |
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[PEDS5:Mesenchymal_hamartoma|Mesenchymal hamartoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[PEDS5:Calcifying_nested_stromal-epithelial_tumour|Calcifying nested stromal-epithelial tumour]] | ||
|Disease | |Disease | ||
| | | | ||
Line 2,821: | Line 3,021: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 12 (ENDOCRINE TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[PEDS5:Follicular_adenoma_of_the_thyroid|Follicular adenoma of the thyroid]] | |[[PEDS5:Follicular_adenoma_of_the_thyroid|Follicular adenoma of the thyroid]] | ||
Line 2,943: | Line 3,163: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 13 (HEAD AND NECK TUMOURS) |
− | + | | | |
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | |[[PEDS5: | + | |[[PEDS5:Squamous_cell_papilloma_of_the_larynx|Squamous cell papilloma of the larynx]] |
|Disease | |Disease | ||
| | | | ||
Line 2,965: | Line 3,194: | ||
| | | | ||
|- | |- | ||
− | |[[PEDS5:Congenital_granular_cell_epulis|Congenital granular cell epulis]] | + | |[[PEDS5:White_sponge_naevus|White sponge naevus]] |
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[PEDS5:Congenital_granular_cell_epulis|Congenital granular cell epulis]] | ||
|Disease | |Disease | ||
| | | | ||
Line 3,129: | Line 3,369: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 14 (THORACIC TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[PEDS5:Fetal_lung_interstitial_tumour|Fetal lung interstitial tumour]] | |[[PEDS5:Fetal_lung_interstitial_tumour|Fetal lung interstitial tumour]] | ||
Line 3,173: | Line 3,433: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 15 (SKIN TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[PEDS5:Hamartomas|Hamartomas]] | |[[PEDS5:Hamartomas|Hamartomas]] | ||
Line 3,284: | Line 3,564: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 16 (GENETIC TUMOUR SYNDROMES) |
− | + | | | |
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[PEDS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]] | ||
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
|- | |- | ||
|[[PEDS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]] | |[[PEDS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]] | ||
− | |Disease | + | |Disease |
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | |- | + | |- |
− | |[[PEDS5:Tuberous_sclerosis|Tuberous sclerosis]] | + | |[[PEDS5:Tuberous_sclerosis|Tuberous sclerosis]] |
|Disease | |Disease | ||
| | | | ||
Line 3,341: | Line 3,641: | ||
|[[PEDS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]] | |[[PEDS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[PEDS5:Hereditary_phaeochromocytoma-paraganglioma_syndromes|Hereditary phaeochromocytoma-paraganglioma syndromes]] | |[[PEDS5:Hereditary_phaeochromocytoma-paraganglioma_syndromes|Hereditary phaeochromocytoma-paraganglioma syndromes]] | ||
Line 3,363: | Line 3,663: | ||
|[[PEDS5:WAGR_syndrome|WAGR syndrome]] | |[[PEDS5:WAGR_syndrome|WAGR syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[PEDS5:Beckwith-Wiedemann_and_related_overgrowth_syndromes|Beckwith-Wiedemann and related overgrowth syndromes]] | |[[PEDS5:Beckwith-Wiedemann_and_related_overgrowth_syndromes|Beckwith-Wiedemann and related overgrowth syndromes]] | ||
Line 3,385: | Line 3,685: | ||
|[[PEDS5:Familial_adenomatous_polyposis|Familial adenomatous polyposis]] | |[[PEDS5:Familial_adenomatous_polyposis|Familial adenomatous polyposis]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[PEDS5:Lynch_syndrome|Lynch syndrome]] | |[[PEDS5:Lynch_syndrome|Lynch syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[PEDS5:Xeroderma_pigmentosum|Xeroderma pigmentosum]] | |[[PEDS5:Xeroderma_pigmentosum|Xeroderma pigmentosum]] | ||
Line 3,429: | Line 3,729: | ||
|[[PEDS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]] | |[[PEDS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[PEDS5:DICER1_syndrome|DICER1 syndrome]] | |[[PEDS5:DICER1_syndrome|DICER1 syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[PEDS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]] | |[[PEDS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]] | ||
Line 3,462: | Line 3,762: | ||
|[[PEDS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]] | |[[PEDS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[PEDS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]] | |[[PEDS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]] |
Revision as of 16:42, 15 July 2024
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.